MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	32.74	9.16	11.87	33.9	11.05	17.38
Short-Term Investments	26.35	34.01	29.68	-	-	4.02
Cash & Short-Term Investments	59.09	43.16	41.54	33.9	11.05	21.4
Cash Growth	29.69%	3.90%	22.56%	206.85%	-48.38%	-26.91%
Accounts Receivable	6.04	4.8	3.7	9.33	2.13	2.77
Other Receivables	-	1.05	0.72	0.36	0.14	0.07
Receivables	6.04	5.85	4.42	9.7	2.27	2.84
Inventory	4.41	2.69	2.85	1.96	1.2	1.38
Prepaid Expenses	-	0.46	0.72	0.29	0.44	0.39
Other Current Assets	-	-	0.17	-	-	0.18
Total Current Assets	69.53	52.16	49.7	45.84	14.95	26.19
Property, Plant & Equipment	24.38	20.8	15.93	3.58	4.03	4.51
Other Intangible Assets	0.05	0.1	0.17	0.23	0.3	0.36
Other Long-Term Assets	0.47	0.44	0.67	0.36	0.47	-
Total Assets	94.42	73.5	66.46	50.02	19.74	31.07
Accounts Payable	8.51	4.1	4.22	5.66	4.69	2.99
Accrued Expenses	-	4.06	4.75	3.2	2.3	2.14
Current Portion of Leases	-	0.42	0.36	0.53	0.6	0.57
Current Unearned Revenue	-	0.65	0.15	0.18	0.76	0.72
Other Current Liabilities	17.74	17.32	8.64	2.49	2.37	1.85
Total Current Liabilities	26.25	26.54	18.13	12.06	10.72	8.27
Long-Term Leases	8.27	6.51	6.35	0.85	1.39	1.74
Long-Term Unearned Revenue	9.29	8.89	7.68	7.45	8	8.5
Pension & Post-Retirement Benefits	0.46	0.4	0.46	0.36	0.29	0.29
Other Long-Term Liabilities	-	-	2.26	18.39	3.92	5
Total Liabilities	44.27	42.34	34.86	39.1	24.33	23.8
Common Stock	50.16	0.22	0.18	0.14	0.08	0.08
Additional Paid-In Capital	-	236	206.25	178.88	143.87	142.19
Retained Earnings	-	-205.05	-174.82	-168.11	-148.51	-134.96
Comprehensive Income & Other	-	-0.01	-0.02	-0.01	-0.02	-0.04
Shareholders' Equity	50.16	31.15	31.6	10.91	-4.58	7.27
Total Liabilities & Equity	94.42	73.5	66.46	50.02	19.74	31.07
Total Debt	8.27	6.93	6.71	1.38	1.99	2.31
Net Cash (Debt)	50.82	36.23	34.83	32.52	9.06	19.09
Net Cash Growth	29.97%	4.02%	7.11%	259.07%	-52.57%	-28.83%
Net Cash Per Share	4.68	3.64	3.86	6.52	2.33	4.92
Filing Date Shares Outstanding	12.82	10.81	9.26	9.2	4.64	3.89
Total Common Shares Outstanding	12.82	10.79	9.22	7.24	3.9	3.89
Working Capital	43.28	25.62	31.57	33.78	4.23	17.93
Book Value Per Share	3.91	2.89	3.43	1.51	-1.18	1.87
Tangible Book Value	50.11	31.05	31.43	10.68	-4.88	6.91
Tangible Book Value Per Share	3.91	2.88	3.41	1.48	-1.25	1.78
Machinery	-	17.63	12.99	5.55	5.2	5.28
Leasehold Improvements	-	3.45	3.38	3.28	3.14	2.9

Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q